Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Clin Lipidol. 2019 Sep 25;13(6):940–946. doi: 10.1016/j.jacl.2019.09.008

Table 1.

Demographics and clinical parameters of subjects with T1D and non-diabetic controls. Values are presented as mean ± SD (range) or n (%).

Control (n=74) T1D (n=175) p-value*
Age (yrs) 15.4 ± 2.2 (12.0 − 20.0) 15.2 ± 2.2 (12.0 − 19.4) 0.547
Sex (%female) 42 F/ 32 M (56.8%) 99 F/ 76 M (56.6%) 1.000
Tobacco Use Now 6 (8.1%) 12 (6.9%) 0.790
HbA1c (%) 5.3 ± 0.3 (4.6 − 5.9) 9.0 ± 1.6 (5.8 − 14.0) < 0.001
Fasting glucose (mg/dL) 82±7(64 − 99) 185 ± 80 (40 − 451) < 0.001
C-peptide (ng/mL) 1.7 ± 0.6 (0.1 − 3.3) 0.1 ± 0.1 (0.1 − 1.3) < 0.001
BMI (kg/m2) 21.8 ± 4.2 (13.8 − 33.5) 22.4 ± 3.4 (15.3 − 35.3) 0.259
Hs-CRP (mg/dL) 0.9 ±1.4 (0.0 – 6.4) 1.3 ± 2.3 (0.1 – 22.0) 0.084
TG (mg/dL) 83.5 ± 41.5 (34.0 − 235.0) 86.8 ± 50.5 (28.0 − 333.0) 0.586
TC (mg/dL) 147.7 ± 28.0 (96.0 − 235.0) 159.4 ± 34.8 (89.0 − 347.0) 0.006
LDL-C (mg/dL) 82.4 ± 22.9 (43.0 − 168.0) 89.9 ± 27.8 (42.0 − 250.0) 0.028
HDL-C (mg/dL) 48.6 ± 9.3 (28.0 − 74.0) 52.1 ± 10.6 (30.0 − 81.0) 0.010
SBP (mmHg) 109.0 ± 8.5 (89.0 − 129.0) 113.1 ± 8.5 (93.0 − 137.0) < 0.001
DBP (mmHg) 64.3 ± 6.1 (49.0 − 79.0) 69.0 ± 6.5 (50.0 − 89.0) < 0.001
Campesterol (A.U.) 1.00 ± 0.35 (0.41 – 1.95) 1.31 ± 0.41 (0.47 – 2.60) < 0.001
β-Sitosterol (A.U.) 1.00 ± 0.36 (0.39 – 2.25) 1.29 ± 0.44 (0.50 – 2.72) < 0.001
Lathosterol (A.U.) 1.00 ± 0.51 (0.32 – 2.52) 0.79 ± 0.38 (0.26 – 2.77) 0.001
*

p-value based on t-tests or Fisher’s exact test. Boldface type highlights statistical significance with p<0.05.